サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562205

欧州の変形性関節症治療：2030年までの市場予測 - 地域分析 - 治療タイプ、適応疾患、エンドユーザー別

Europe Osteoarthritis Therapy Market Forecast to 2030 - Regional Analysis - by Therapy Type, Disease Indication, and End User

出版日
ページ情報
英文 108 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
欧州の変形性関節症治療：2030年までの市場予測 - 地域分析 - 治療タイプ、適応疾患、エンドユーザー別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 108 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の変形性関節症治療市場は、2022年に49億7,151万米ドルと評価され、2030年には87億4,393万米ドルに達すると予測され、2022年から2030年までのCAGRは7.3%と推定されます。

再生医療の利用可能性が欧州の変形性関節症治療市場を牽引

再生医療は、OAを治療するための従来の治療法に代わる新たな選択肢であり、変革の可能性を秘めています。再生医療は、OAを治療するために身体の免疫系を標的とした生体医工学、生体材料、細胞療法を利用します。また、臨床研究者は、患者の（自己）細胞を用いて患者の関節軟骨を固定する方法を開発しました。さらに、再生療法の選択肢として、"マトリックス誘導自己軟骨細胞移植（MACI）"があります。MACIは、軟骨の小さな部分を修復し、最終的にはOAを予防または先延ばしすることができます。また、複数のメーカーが再生療法に焦点を当てた製品を開発しています。PRP療法、幹細胞療法、ヒアルロン酸注射、プロロセラピーといった非外科的アプローチへの傾斜が高まっていることは、再生医療の採用を促進すると思われます。OAに苦しむ患者は、非薬物療法を用いて治療することができます。再生療法の選択肢は、最終的に痛みを軽減し、OAに苦しむ個人の全体的な生活の質を向上させることにより、関節機能を改善することができます。したがって、再生医療の採用が増加することで、予測期間中に変形性関節症治療市場に新たなビジネスチャンスが生まれると期待されています。

欧州の変形性関節症治療市場概要

欧州の変形性関節症治療市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。同地域における変形性関節症治療薬の迅速な製品承認と高度なヘルスケアインフラが、市場成長の最も有力な要因です。Journal of Health Monitoring誌のレポートによると、変形性関節症はドイツで最も一般的な関節疾患です。変形性関節症は上肢（指、手、肩）に起こるため、関節の痛みや機能低下は生活の質の低下につながる可能性が高いです。したがって、ドイツの高齢化に伴い、変形性関節症の有病率は上昇し続け、その結果、ヘルスケアシステムに高い負担がかかることになります。2020年に発表された世界保健機関（WHO）の報告書によると、ドイツにおける変形性関節症の死亡者数は、総死亡者数の0.05％を占めています。さらに、新製品の発売は市場の成長を促進します。例えば、2023年5月、グルネンタール社は、現在臨床第3相開発中の非オピオイド系治験薬「レジニフェラトキシン（RTX）」が、米国食品医薬品局（USFDA）により膝関節OAを治療する画期的治療薬として承認されたことを発表しました。レジニフェラトキシンは、長期にわたる疼痛緩和と患部関節の機能改善をもたらし、オピオイドを使用しない有意義な治療選択肢となり得る。

欧州の変形性関節症治療薬市場の収益と2030年までの予測（百万米国ドル）

欧州の変形性関節症治療市場のセグメンテーション

欧州の変形性関節症治療市場は、治療タイプ、適応疾患、エンドユーザー、国に分類されます。

治療タイプ別に見ると、欧州の変形性関節症治療市場は、経皮的電気神経刺激（TENS）、作業療法、理学療法、多血小板血漿（PRP）療法＆間質血管分画、プロロセラピー、その他に区分されます。理学療法分野が2022年に最大の市場シェアを占めました。

適応疾患別では、欧州の変形性関節症治療市場は変形性膝関節症、変形性脊椎症、変形性足関節症、変形性肩関節症、変形性手関節症、その他に区分されます。変形性膝関節症セグメントは、2022年の欧州の変形性関節症治療市場で最大のシェアを占めました。

エンドユーザー別に見ると、欧州の変形性関節症治療市場は、病院・クリニック、専門クリニック、外来手術センター、在宅ケア、その他に分類されます。2022年の欧州の変形性関節症治療市場は、在宅ケア分野が最大シェアを占めました。

国別では、欧州の変形性関節症治療市場は、英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。2022年の欧州の変形性関節症治療市場シェアはドイツが独占。

Zimmer Biomet Holdings Inc、DePuy Synthes Inc、Bioventus Inc、Omron Healthcare Inc、Exactech Inc、Medi GmbH &Co KGは、欧州の変形性関節症治療市場で事業を展開する主要企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 変形性関節症治療市場情勢

  • パイプライン分析
    • 臨床試験パイプライン分析

第5章 欧州の変形性関節症治療市場：主要市場力学

  • 市場促進要因
    • 変形性関節症の有病率の上昇
    • 革新的な治療オプションによる薬物依存の軽減
  • 市場抑制要因
    • 製品回収
  • 市場機会
    • 再生医療の利用可能性
  • 今後の動向
    • より効果的な治療オプション
  • 促進要因と抑制要因の影響

第6章 変形性関節症治療市場：欧州市場分析

    • 変形性関節症治療市場収益、2020-2030年

第7章 欧州の変形性関節症治療市場分析：治療タイプ別

  • 経皮的電気神経刺激療法（TENS）
  • 作業療法
  • 理学療法
  • 多血小板血漿療法と間質血管分画療法
  • プロロセラピー
  • その他

第8章 欧州の変形性関節症治療市場分析：適応疾患別

  • 変形性膝関節症
  • 脊椎変形性関節症
  • 変形性足関節症
  • 肩変形性関節症
  • 手の変形性関節症
  • その他

第9章 欧州の変形性関節症治療市場分析：エンドユーザー別

  • 病院およびクリニック
  • 専門クリニック
  • 外来手術センター
  • 在宅医療
  • その他

第10章 欧州の変形性関節症治療市場：国別分析

  • 欧州市場概要
    • 欧州
      • 英国
      • ドイツ
      • フランス
      • イタリア
      • スペイン
      • その他欧州

第11章 業界情勢

  • 変形性関節症治療市場における成長戦略
  • 有機的展開
  • 無機的展開

第12章 企業プロファイル

  • Zimmer Biomet Holdings Inc
  • DePuy Synthes Inc
  • Bioventus Inc
  • Omron Healthcare Inc
  • Exactech Inc
  • Medi GmbH & Co KG

第13章 付録

図表

List Of Tables

  • Table 1. Osteoarthritis Therapy Market Segmentation
  • Table 2. Ongoing Clinical Trial of Osteoarthritis
  • Table 3. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 4. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 5. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 6. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 7. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 8. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 9. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 10. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 11. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 12. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 13. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 14. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 15. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 16. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 17. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 18. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 19. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 20. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 21. Organic Developments Done by Companies
  • Table 22. Inorganic Developments Done by Companies

List Of Figures

  • Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
  • Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
  • Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
  • Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
  • Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
  • Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Europe: Osteoarthritis Therapy Market - Revenue by Key Countries Revenue 2022 (US$ Million)
  • Figure 26. Europe: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 27. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 31. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 33. Growth Strategies in the Osteoarthritis Therapy market
目次
Product Code: BMIRE00030422

The Europe osteoarthritis therapy market was valued at US$ 4,971.51 million in 2022 and is expected to reach US$ 8,743.93 million by 2030; it is estimated to register a CAGR of 7.3% from 2022 to 2030 .

Availability of Regenerative Medicine Drives Europe Osteoarthritis Therapy Market

Regenerative medicine is a new and potentially transformative alternative to traditional therapy options to treat OA. Regenerative medicine utilizes biomedical engineering, biomaterials, and cell therapies that target the body's immune system to treat OA. Also, clinical researchers have developed methods to fix the articular cartilage of patients using patients' (autologous) cells. Further, regenerative therapy options use "Matrix-Induced Autologous Chondrocyte Implantation (MACI)." MACI can repair small areas of cartilage, ultimately preventing or postponing OA. Also, several manufacturers are developing products focused on regenerative therapy. Rising inclination toward non-surgical approaches such as PRP therapy, stem cell therapy, hyaluronic acid injections, and prolotherapy would propel the adoption of regenerative medicine. Patients suffering from OA can be treated using non-pharmacological therapies. Regenerative therapy options can improve joint functions by ultimately reducing pain and enhancing the overall quality of life for individuals suffering from OA. Therefore, increasing adoption of regenerative medicine is expected to open new business opportunities in the osteoarthritis therapy market during the forecast period.

Europe Osteoarthritis Therapy Market Overview

Europe osteoarthritis therapy market is segmented as Germany, the UK, France, Italy, Spain, and the Rest of Europe. Fast product approvals in the region for osteoarthritis treatment drugs and advanced healthcare infrastructure are the most influential factors responsible for market growth. According to the Journal of Health Monitoring report, osteoarthritis is the most common joint disease in Germany. Joint pain and loss of function are likely to result in loss of quality of life as osteoarthritis is caused in the upper extremities (fingers, hands, and shoulders). Therefore, with the aging of Germany's population, osteoarthritis prevalence will continue to rise, resulting in a high burden on the healthcare system. According to the World Health Organization (WHO) report published in 2020, osteoarthritis deaths in Germany account for 0.05% of total deaths. Further, new product launches enhance the market growth. For instance, in May 2023, Grunenthal announced receiving approval for investigational non-opioid medicine "Resiniferatoxin (RTX)," currently undergoing Clinical Phase 3 development standing as a breakthrough therapy by the US Food and Drug Administration (USFDA) to treat knee OA. Resiniferatoxin can become a meaningful non-opioid treatment option, providing long-lasting pain relief and functional improvement of the affected joint.

Europe Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)

Europe Osteoarthritis Therapy Market Segmentation

The Europe osteoarthritis therapy market is categorized into therapy type, disease indications, end user, and country.

Based on therapy type, the Europe osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share in 2022.

In terms of disease indications, the Europe osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held the largest share of Europe osteoarthritis therapy market in 2022.

Based on end users, the Europe osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held the largest share of Europe osteoarthritis therapy market in 2022.

By country, the Europe osteoarthritis therapy market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe osteoarthritis therapy market share in 2022.

Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc, and Medi GmbH & Co KG are some of the leading companies operating in the Europe osteoarthritis therapy market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

  • 4.1 Pipeline Analysis
    • 4.1.1 Clinical Trial Pipeline Analysis

5. Europe Osteoarthritis Therapy Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Osteoarthritis
    • 5.1.2 Innovative Therapy Options Reducing Dependency on Medications
  • 5.2 Market Restraints
    • 5.2.1 Product Recall
  • 5.3 Market Opportunities
    • 5.3.1 Availability of Regenerative Medicine
  • 5.4 Future Trends
    • 5.4.1 More Effective Treatment Options
  • 5.5 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - Europe Market Analysis

  • 6.1 Overview
    • 6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

7. Europe Osteoarthritis Therapy Market Analysis - by Therapy Type

  • 7.1 Overview
  • 7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
    • 7.2.1 Overview
    • 7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Occupational Therapy
    • 7.3.1 Overview
    • 7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Physical Therapy
    • 7.4.1 Overview
    • 7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
    • 7.5.1 Overview
    • 7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Prolotherapy
    • 7.6.1 Overview
    • 7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Osteoarthritis Therapy Market Analysis - by Disease Indication

  • 8.1 Overview
  • 8.2 Knee Osteoarthritis
    • 8.2.1 Overview
    • 8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Spine Osteoarthritis
    • 8.3.1 Overview
    • 8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Foot and Ankle Osteoarthritis
    • 8.4.1 Overview
    • 8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Shoulder Osteoarthritis
    • 8.5.1 Overview
    • 8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Hand Osteoarthritis
    • 8.6.1 Overview
    • 8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Osteoarthritis Therapy Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Hospitals and Clinics
    • 9.2.1 Overview
    • 9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Specialty Clinics
    • 9.3.1 Overview
    • 9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Ambulatory Surgical Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Homecare
    • 9.5.1 Overview
    • 9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Osteoarthritis Therapy Market - Country Analysis

  • 10.1 Europe Market Overview
    • 10.1.1 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.1.4 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.1.5 United Kingdom: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.1.1.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Germany: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.2.4 Germany: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.2.5 Germany: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.1.1.3 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 France: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.3.4 France: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.3.5 France: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.1.1.4 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.3 Italy: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.4.4 Italy: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.4.5 Italy: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.1.1.5 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.3 Spain: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.5.4 Spain: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.5.5 Spain: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.1.1.6 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.6.4 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.6.5 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the osteoarthritis therapy market
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.1 Inorganic Developments
    • 11.1.1 Overview

12. Company Profiles

  • 12.1 Zimmer Biomet Holdings Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 DePuy Synthes Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Bioventus Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Omron Healthcare Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Exactech Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Medi GmbH & Co KG
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners